Elevation Oncology

888 7th Ave., 12th Floor New York, New York 10106
  • Company Industry
    Biotechnology
  • Company Type
    Private

Our first journey at Elevation Oncology is the Phase 2 CRESTONE study, leading straight towards our first summit: NRG1 fusions. The tumor-agnostic approach we’ve chosen is non-traditional, but we’ve assembled a team of collaborators capable of blazing the trail and developing the tools and techniques that will smooth the way for the next summits to follow.

The first step in any precision oncology journey is genomic testing. These test results become the map that guides not only individual patient treatment decisions but also our path as precision therapeutic developers. That is why we’ve started building a network of partnerships with groups that are on the leading edge of genomic testing for cancer. In July, we announced our first set of partnerships with Ashion Analytics, Caris Life Sciences, Strata Oncology, and Tempus. With the addition of the US Oncology Research STAR network, just announced yesterday, we can now identify NRG1 fusion positive patients from over 400 clinical sites across the US.

Current Job Openings

View All Jobs From Employer

Join us to start saving your Favorite Jobs!

Sign In Create Account
888 7th Ave., 12th Floor
New York New York 10106
United States

  • Office Phone 9197135251
  • Career Contact Kim Krause

Share this Company:

Elevation Oncology

Powered ByCareerCast